Mark Plavsic, Chief Technical Officer: Fate Therapeutics FATE Sell · Filed 23/01/11

Trade details

Type: Insider sale
Amount: $17,910.32
Shares · price: 3,418 sh · $5.24 a share
Held after: 123,705 sh
Stock: Fate Therapeutics FATE
Person: Mark PlavsicChief Technical Officer
Trade date: 23/01/10
Filed: 23/01/11
Days to filing: 1 days

Sold 2.7% of holdings

Share of holding sold: 2.7%

Fate Therapeutics trades, last 26 weeks

What else happened in Fate Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/11~23/02/09

Mark Plavsic's recent trades

Mark PlavsicCTO
Planned saleAura Biosciences
Planned sale
Aura Biosciences
AURA
$80.3K
15,890 sh
$80.3K
Filed 02/17
Traded 02/17
Mark PlavsicCTO
SellAura Biosciences
Sell
Aura Biosciences
AURA
$80.2K
15,890 sh
$80.2K
Filed 02/17
Traded 02/17
Mark PlavsicCTO
Planned saleAura Biosciences
Planned sale
Aura Biosciences
AURA
$77.3K
12,169 sh
$77.3K
Filed 25/10/16
Traded 25/10/16
Mark PlavsicCTO
SellAura Biosciences
Sell
Aura Biosciences
AURA
$77.3K
12,169 sh
$77.3K
Filed 25/10/16
Traded 25/10/16
Mark PlavsicOfficer
Planned saleAura Biosciences
Planned sale
Aura Biosciences
AURA
$16.7K
2,151 sh
$16.7K
Filed 25/02/18
Traded 25/02/18